Failure of Relaxin in the Treatment of Scleroderma

Open Access
Publisher Website
Google Scholar
Abstract
Three women with typical scleroderma and one woman with changes resembling both rheumatoid arthritis and scleroderma were each treated with a brand of relaxin four times a day intramuscularly for 2 to 4 weeks. In the dosage used (20 mg.), this form of therapy was without value, despite its cost ([pound sterling]10 per day).